These Healthcare and Bank Stocks Had Incredible Runs in 2025. Why Gains Will Continue This Year.
With a 58% gain, CVS Health had its best year since 1982—and it wasn't the only strong performer.
Fiscal Year: July - June
Cardinal Health, Inc. (CAH), listed on the NYSE, has a market capitalization of $. As of Jan 05, 2026, the stock is trading at $205.72 per share, offering investors a clear view of its current market value. Cardinal Health, Inc. is a prominent player in the industry sector, attracting both institutional and retail investors due to its performance and potential.
With a P/E ratio of 31.04, investors can assess the stock's valuation in comparison to its earnings. A P/E ratio is a crucial indicator for value investors, showing whether the stock is over or undervalued relative to its current earnings. Cardinal Health, Inc. also offers a dividend yield of 0.99%, making it an attractive option for income-focused investors who seek regular dividends.
Our Discounted Cash Flow (DCF) analysis reveals that Cardinal Health, Inc. (CAH) may be undervalued compared to its intrinsic worth. However, to see the exact DCF fair value, please Login or Upgrade for access.
The proprietary SS Score for Cardinal Health, Inc. is a unique metric that analyzes the company's financial health and growth potential. The score takes into account critical factors such as revenue growth, net income, free cash flow (FCF) compound annual growth rate (CAGR), the trend of shares outstanding, and the debt-to-FCF ratio. This helps investors to make a more informed decision, as an undervalued stock might still have poor financial fundamentals.
To view the detailed SS Score for Cardinal Health, Inc., Login or Upgrade for access.
The Price to Free Cash Flow (P/FCF) ratio for Cardinal Health, Inc. is 10.98, offering insights into how much investors are paying for the company's free cash flow. A lower P/FCF ratio typically suggests that the stock is undervalued, while a higher ratio may indicate overvaluation.
In summary, Cardinal Health, Inc. (CAH) has shown consistent financial performance, as illustrated by the financial charts above, which track its revenue growth, net income, free cash flow, and shares outstanding over the past several years. These metrics provide investors with key insights into the company's past and projected future performance. Investors should use the SS Score alongside the DCF Fair Value to make better-informed decisions about whether to buy or hold the stock.
*This analysis is for informational purposes only and does not constitute investment advice. Always read the company's 10-K filings and do your own research before making any investment decisions.
Whether Cardinal Health, Inc. (CAH) is a good stock to buy depends on various factors, including its financial health, market conditions, and your investment strategy. Our analysis indicates that the stock may be undervalued compared to its intrinsic value. However, it is important to assess the SS Score and review the company's fundamentals before making any investment decisions.
The fair value of Cardinal Health, Inc. (CAH) is determined through our Discounted Cash Flow (DCF) analysis. This value represents the intrinsic worth of the stock based on its expected future cash flows. To view the specific fair value, consider subscribing to our service for complete access.
The SS Score is a proprietary financial quality metric that assesses factors such as revenue growth, net income, free cash flow growth, and debt levels. It helps investors evaluate the overall financial health of Cardinal Health, Inc.. To access the full SS Score, consider upgrading your subscription.
Cardinal Health, Inc. is a significant player in the industry sector, with a market capitalization of $ and a competitive P/E ratio of 31.04. Investors should compare these metrics with industry peers to gauge whether Cardinal Health, Inc. is outperforming or underperforming within its sector.
With a 58% gain, CVS Health had its best year since 1982—and it wasn't the only strong performer.
The ProShares S&P 500 Dividend Aristocrat ETF (NOBL) underperformed SPY in 2025, gaining 7.2% versus SPY's 18.42%. Despite average underperformance, select Aristocrats like CAH (+74.18%), ALB (+66.90%...
In October, we (my wife and I) received a dividend income total of $3,948.78. Crushing it for an off-month – thanks to Vanguard (VOO) and Fidelity (FXAIX) for paying in October. We had quite a few div...
Cardinal Health, Inc. (CAH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript
Selling options can generate 12-15% annual income but requires discipline, risk management, and due diligence. We explain why selling cash-covered puts and covered calls is a relatively safe choice fo...
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...
Out with the old (tech), in with the new (healthcare). After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of...
Cardinal Health, Inc. ( CAH) UBS Global Healthcare Conference 2025 November 11, 2025 8:45 AM EST Company Participants Matt Sims - Vice President of Investor Relations Aaron Alt - Chief Financial Offi...
Cardinal Health (CAH) is evolving into a specialty-focused healthcare leader, leveraging acquisitions and managed services for higher profitability and efficiency. CAH's financials show strong gross p...
Grants are a part of $5 million commitment from Cardinal Health Foundation and awarded by the National Association of Free & Charitable Clinics Grants are a part of $5 million commitment from Cardinal...
DUBLIN, Ohio , Nov. 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital s...
Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal Health's MSO platforms to ~3,000 pr...
Cardinal Health CEO Jason Hollar discusses medication affordability, the Obamacare subsidies battle and more on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusiness #healthcare #medici...
The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed SPY in 2025, with a 6.27% YTD gain versus SPY's 17.8%. Despite overall underperformance, select Aristocrats like CAT, CAH, CHRW...
Cardinal Health Inc.'s (NYSE:CAH) stock surged on Thursday as the healthcare services company reported upbeat first-quarter 2026 earnings, with adjusted earnings of $2.55 per share, beating the consen...
Cardinal Health, Inc. ( CAH) Q1 2026 Earnings Call October 30, 2025 8:30 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar - CEO & Director Aaron Alt - Chief F...
Drug distributor Cardinal Health raised its annual adjusted profit forecast on Thursday after beating estimates for first-quarter profit on strong demand for costly specialty medicines and branded dru...
Revenue increased 22% to $64 billion GAAP 1 operating earnings increased 18% to $668 million; GAAP diluted EPS increased 11% to $1.88 Non-GAAP operating earnings increased 37% to $857 million, driven ...
The planned 230,000 square-foot plant is the healthcare company's latest step in a 10-year plan to modernize and expand its distribution network.
DUBLIN, Ohio , Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distribution center in Indianapolis, Indiana that will further expand and mod...
Dividend Aristocrats, tracked by NOBL, outperformed SPY in August but lagged year-to-date, with notable dispersion among individual stock returns. Dividend growth remains robust, with 55 of 69 Aristoc...
Cardinal Health, Inc. (NYSE:CAH) Bank of America Global Healthcare Conference 2025 September 24, 2025 11:10 AM EDT Company Participants Matt Sims - Vice President of Investor Relations Jason Hollar -...
DUBLIN, Ohio , Sept. 23, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2026 on October 30, prior to the opening of trading on th...
DUBLIN, Ohio , Sept. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today is showcasing its newly operational Consumer Health Logistics Center, a 350,000-square-foot facility in Groveport, Ohio.
Below estimates were sourced from SimplyWallSt and are intended for educational purposes only as a baseline for the analysis.
| Year | FCF Estimate | % | # Analysts |
|---|---|---|---|
| 2026 | 2.55B | Analyst x5 | |
| 2027 | 3.27B | 28.31% | Analyst x4 |
| 2028 | 3.76B | 14.97% | Analyst x3 |
| 2029 | 4.03B | 7.20% | Analyst x2 |
| 2030 | 4.39B | 8.96% | Analyst x2 |
| 2031 | 4.60B | 4.88% | Est @4.9% |
| 2032 | 4.79B | 4.15% | Est @4.1% |
| 2033 | 4.97B | 3.64% | Est @3.6% |
| 2034 | 5.12B | 3.06% | Est @3.1% |
| 2035 | 5.27B | 2.83% | Est @2.8% |
Below are the FCF estimates with the discount factor and the calculated present value with the terminal value that led the results above.
| Year | FCF | Discount Factor | PV of Future FCF |
|---|---|---|---|
| 2024A | 3.25B | 1.00 | 3.25B |
| 2025A | 1.85B | 1.00 | 1.85B |
| 2026E | 2.55B | 1.08 | 2.35B |
| 2027E | 3.27B | 1.17 | 2.79B |
| 2028E | 3.76B | 1.27 | 2.96B |
| 2029E | 4.03B | 1.37 | 2.93B |
| 2030E | 4.39B | 1.49 | 2.95B |
| 2031E | 4.60B | 1.61 | 2.86B |
| 2032E | 4.79B | 1.74 | 2.75B |
| 2033E | 4.97B | 1.88 | 2.64B |
| 2034E | 5.12B | 2.04 | 2.51B |
| 2035E | 5.27B | 2.21 | 2.38B |
| Terminal | 93.98B | 2.21 | 42.57B |
The information given by Studying Stocks and provided in the web and/or mobile applications (Platforms) is only factual information and should not be considered financial advice.
Any information contained in this website has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
When creating an account, you acknowledge that you are:
We retain the right to cancel your account for any reason, or refuse your account creation request.
The information on our Platforms is not comprehensive and is intended to provide a summary of the subject matter covered. While we use all reasonable attempts to ensure the accuracy and completeness of the data and information on our Platforms, to the extent permitted by law, we make no warranty regarding the information on these Platforms. You should monitor any changes to the information contained on these Platforms.
Furthermore we make no commitments in regards to the minimum amount of uptime that our platforms will maintain, although we will make ever reasonable attempt to ensure that the platforms are operational. Therefore, any reference of "latest", "current" and related words about the financial data presented here may not be up to date with the financial markets or represent reality of the information.
We are not liable to you or anyone else if interference with or damage to your computer systems occurs in connection with the use of these Platforms or a linked website. You must take your own precautions to ensure that whatever you select for your use from our Platforms is free of viruses or anything else (such as worms or Trojan horses) that may interfere with or damage the operations of your computer systems.
We may, from time to time and without notice, change or add to the Platforms (including the Terms) or the information, products or services described in it. However, we do not undertake to keep the Platforms updated. We are not liable to you or anyone else if errors occur in the information or the Platforms is not up-to-date.
Our Platforms may contain links to websites operated by third parties. Those links are provided for convenience and may not remain current or be maintained. Unless expressly stated otherwise, we do not endorse and are not responsible for the content on those linked websites and have no control over or rights in those linked websites.
These Platforms are for your personal, non-commercial use only. You may not modify, copy, distribute, transmit, display, perform, reproduce, publish, license, commercially exploit, create derivative works from, transfer, or sell any Content, software, products or services contained within these Platforms. You may not use these Platforms, or any of its Content, to further any commercial purpose, including any advertising or advertising revenue generation activity on your own website.
You must not do any act that we would deem to be inappropriate, is unlawful or is prohibited by any laws applicable to these Platforms, including but not limited to:
If we allow you to post any information to our Platforms, we have the right to take down this information at our sole discretion and without notice.
To the maximum extent permitted by law, we make no warranties or representations about these Platforms or the Content, including but not limited to warranties or representations that they will be complete, accurate or up-to-date, that access will be uninterrupted or error-free or free from viruses, or that these Platforms will be secure.
We reserve the right to restrict, suspend or terminate without notice your access to these Platforms, any Content, or any feature of these Platforms at any time without notice and we will not be responsible for any loss, cost, damage or liability that may arise as a result.
To the maximum extent permitted by law, in no event shall we be liable for any direct and indirect loss, damage or expense – irrespective of the manner in which it occurs – which may be suffered due to your use of our Platforms and/or the information or materials contained on it, or as a result of the inaccessibility of these Platforms and/or the fact that certain information or materials contained on it are incorrect, incomplete or not up-to-date.
This website utilises cookies. If you do not have cookies enabled in your web browser some functions of the site may not work as intended.